P1157: PHASE II STUDY OF GLOFITAMAB, POSELTINIB AND LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE B CELL LYMPHOMAS

• Ja Min Byun,
• Sung-Soo Yoon,
• Junshik Hong,
• Dong-Yeop Shin,
• Youngil Koh

Affiliations

Ja Min Byun

1 Seoul National University Hospital, Seoul, Korea, Rep. of South

Sung-Soo Yoon

1 Seoul National University Hospital, Seoul, Korea, Rep. of South

Junshik Hong

1 Seoul National University Hospital, Seoul, Korea, Rep. of South

Dong-Yeop Shin

1 Seoul National University Hospital, Seoul, Korea, Rep. of South

Youngil Koh

1 Seoul National University Hospital, Seoul, Korea, Rep. of South